PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.\', \'Department of Medicinal Chemistry and Molecular Pharmacolgy, Purdue University, West Lafayette, IN 47907, USA.\', \'Department of Excellence of Pharmacy, University of Naples Federico II, 80131, Naples, Italy.\', \'Department of Biochemistry, Purdue University, West Lafayette, IN 47907, USA.\', \'Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cmdc.202000223
?:hasPublicationType
?:journal
  • ChemMedChem
is ?:pmid of
?:pmid
?:pmid
  • 32324951
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.137
?:rankingScore_hIndex
  • 88
?:title
  • Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32324951>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32324951>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all